Kestra Advisory Services’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $65.2M | Buy |
351,326
+12,671
| +4% | +$2.35M | 0.32% | 50 |
|
|
2025
Q1 | $71M | Sell |
338,655
-8,507
| -2% | -$1.78M | 0.34% | 33 |
|
|
2024
Q4 | $61.7M | Sell |
347,162
-7,607
| -2% | -$1.35M | 0.34% | 53 |
|
|
2024
Q3 | $70.1M | Sell |
354,769
-17,681
| -5% | -$3.49M | 0.39% | 39 |
|
|
2024
Q2 | $63.9M | Buy |
372,450
+66,345
| +22% | +$11.4M | 0.36% | 45 |
|
|
2024
Q1 | $55.7M | Buy |
306,105
+16,994
| +6% | +$3.09M | 0.37% | 39 |
|
|
2023
Q4 | $44.8M | Buy |
289,111
+5,962
| +2% | +$924K | 0.36% | 45 |
|
|
2023
Q3 | $42.2M | Sell |
283,149
-53,877
| -16% | -$8.03M | 0.42% | 37 |
|
|
2023
Q2 | $45.4M | Buy |
337,026
+41,499
| +14% | +$5.59M | 0.45% | 31 |
|
|
2023
Q1 | $47.1M | Sell |
295,527
-60,875
| -17% | -$9.7M | 0.51% | 28 |
|
|
2022
Q4 | $57.6M | Sell |
356,402
-1,563
| -0.4% | -$253K | 0.51% | 28 |
|
|
2022
Q3 | $48M | Buy |
357,965
+69,687
| +24% | +$9.35M | 0.51% | 26 |
|
|
2022
Q2 | $44.2M | Buy |
288,278
+15,852
| +6% | +$2.43M | 0.45% | 33 |
|
|
2022
Q1 | $44.2M | Sell |
272,426
-56,292
| -17% | -$9.13M | 0.46% | 33 |
|
|
2021
Q4 | $44.5M | Sell |
328,718
-6,828
| -2% | -$925K | 0.45% | 34 |
|
|
2021
Q3 | $36.2M | Buy |
335,546
+24,493
| +8% | +$2.64M | 0.36% | 51 |
|
|
2021
Q2 | $35M | Buy |
311,053
+5,411
| +2% | +$609K | 0.4% | 43 |
|
|
2021
Q1 | $33.1M | Buy |
305,642
+7,785
| +3% | +$843K | 0.42% | 40 |
|
|
2020
Q4 | $31.4M | Buy |
297,857
+65,546
| +28% | +$6.9M | 0.36% | 52 |
|
|
2020
Q3 | $20.4M | Buy |
+232,311
| New | +$20.4M | 0.38% | 49 |
|